$Use of oral bisphosphonates in primary prevention of fractures in postmenopausal women: a population-based cohort study.$

Use of oral bisphosphonates in primary prevention of fractures in postmenopausal women: a population-based cohort study.

OBJECTIVE:To compare incidence of first osteoporotic fracture in two cohorts of postmenopausal women, one treated with bisphosphonates and the other only with calcium and vitamin D. DESIGN:Retrospective population cohort study with paired matching based on data from electronic health records. SETTIN...

Full description

Bibliographic Details
Main Authors:	Jordi Real, Gisela Galindo, Leonardo Galván, María Antonia Lafarga, María Dolors Rodrigo, Marta Ortega
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4393307?pdf=render

Similar Items

Intravenous bisphosphonates for postmenopausal osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Intravenous Bisphosphonates for Postmenopausal Osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Incomplete atypical femoral fractures after bisphosphonate use in postmenopausal women
by: Umut Canbek, et al.
Published: (2019-09-01)

Oral bisphosphonates in a postmenopausal population: a systemic review study
by: Chu CC, et al.
Published: (2013-10-01)

Incidence and predictors of fragility fracture in postmenopausal rheumatoid arthritis patients receiving oral bisphosphonates: a longitudinal observational study
by: Yuji Kishimoto, et al.
Published: (2022-02-01)

Outcomes of Treatment in Patients with Elderly Postmenopausal Osteoporosis: Comparision of Oral and Parenteral Bisphosphonates
by: Ahmet Aslan, et al.
Published: (2018-08-01)

The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks.
by: van Staa, T, et al.
Published: (2007)

TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH NITROGEN CONTAINING BISPHOSPHONATES, EARLY SIDE EFFECTS AND THEIR PREVENTION
by: O V Yakushevskaya, et al.
Published: (2013-12-01)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
by: Hawley, S, et al.
Published: (2014)

Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study.
by: Prieto-Alhambra, D, et al.
Published: (2014)

Radiological Factors Associated with Bisphosphonate Treatment Failure and Their Impact on Fracture Healing in Postmenopausal Women with Osteoporotic Vertebral Fractures
by: Hong Jin Kim, et al.
Published: (2023-06-01)

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
by: Pazianas, M, et al.
Published: (2012)

Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapy
by: Kostoff MD, et al.
Published: (2014-04-01)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
by: Pazianas, M, et al.
Published: (2010)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
by: Michael Pazianas, et al.
Published: (2010-07-01)

Oral bisphosphonates as the therapy of choice in patients with moderate risk of fractures
by: L. A. Marchenkova, et al.
Published: (2020-05-01)

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
by: Ariane H&ouml;er, et al.
Published: (2008-12-01)

A case of atypical femur fracture during long-term treatment with bisphosphonates in patient with postmenopausal osteoporosis
by: Kira E. Zotkina, et al.
Published: (2019-11-01)

Prevention of subsequent fractures of hip with use of bisphosphonates in Pakistan population
by: M.A. Ghazi, et al.
Published: (2017-09-01)

Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
by: Francisco Bandeira, et al.
Published: (2020-07-01)

Prevention of Subsequent Hip Fractures among Geriatric Population with Use of Bisphosphonates.
by: Syed Kamran Ali Shah, et al.
Published: (2022-08-01)

Atypical Femur Fractures in Patients Treated with Bisphosphonates: Identification, Management, and Prevention
by: Judith Sarah Bubbear
Published: (2016-10-01)

A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures
by: Sarah Davis, et al.
Published: (2016-10-01)

Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women
by: Lai, Pauline Siew Mei, et al.
Published: (2011)

Modern principles for the diagnosis and treatment of postmenopausal osteoporosis: a focus on bisphosphonates
by: I. B. Belyaeva, et al.
Published: (2020-08-01)

The Effect of Bisphosphonate Treatment on Blood Lipid Parameters in Patients with Postmenopausal Osteoporosis
by: Canan Tıkız, et al.
Published: (2005-03-01)

Long-term Treatment with Bisphosphonates and Their Side Effects in Postmenopausal Osteoporosis - Review
by: Merih Sarıdoğan, et al.
Published: (2010-12-01)

Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
by: Jiaqi Wu, et al.
Published: (2018-08-01)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
by: Oliver Bock, et al.
Published: (2008-06-01)

Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations
by: John Sunyecz
Published: (2008-12-01)

Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study.
by: Tineke A C M van Geel, et al.
Published: (2018-01-01)

Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
by: van Staa, T, et al.
Published: (2007)

Denosumab for the prevention of osteoporotic fractures in postmenopausal women
by: N Waugh, et al.
Published: (2011-05-01)

Corrigendum: A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures
by: Sarah Davis, et al.
Published: (2018-03-01)

Carpal Tunnel Syndrome Associated with Oral Bisphosphonates. A Population-Based Cohort Study.
by: Alfonso Carvajal, et al.
Published: (2016-01-01)

Bisphosphonate-related atypical femoral fracture
by: Jung-Hsiu Hsu
Published: (2013-06-01)

Bisphosphonate-related Femoral Shaft Fracture
by: Jesse Kellar, et al.
Published: (2020-02-01)

A postmenopausal osteoporotic woman losing bone mineral density despite bisphosphonates
by: Lai PSM, et al.
Published: (2013-10-01)

Fracture during oral bisphosphonate therapy is associated with deteriorated bone material strength index
by: Nogués, X, et al.
Published: (2017)

Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years
by: Joan C. Lo, et al.
Published: (2020-12-01)